Telomerase activity in needle biopsies from prostate cancer and benign prostates

European Journal of Clinical Investigation

Volumn 30, Issue 4, 2000, Pages 330-335

  Wymenga, L F A ^a,b   Wisman, G B A ^a   Veenstra, R ^a   Ruiters, M H J ^a   Mensink, H J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

Biopsy; Needle; Prostate cancer; Telomerase; Telomere

Indexed keywords

TELOMERASE;

ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; ENZYME ACTIVITY; HISTOLOGY; HUMAN; MALE; METASTASIS; NEEDLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; TRANSRECTAL ULTRASONOGRAPHY; URETHRA DISEASE;

BIOPSY, NEEDLE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034012611     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00636.x     Document Type: Article

References (27)

1. 1 Stamey TA, McNeal JE. Adenocarcinoma of the prostate. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, editors. Campbell's Urology. 6th ed. Philadelphia: W.B. Saunders; 1992:2;1159-221.
2. 2 Lu-Yao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet 1994;343:251-4.
3. 3 Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996;56:218-22.
4. 4 Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y. Telomerase activity in primary prostate cancer. J Urol 1997;157:1161-5.
5. 5 Israeli RS, Grob M, Fair WR. Prostate-specific membrane antigen and other prostatic tumour markers on the horizon. Urol Clin N Am 1997;24:439-50.
6. 6 Greider CW, Blackburn EH. Telomeres, telomerase and cancer. Scientific Am 1996;274:80-5.
7. 7 Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91:9857-60.
8. 8 Axelrod N. of telomeres and tumours. Nat Med 1996;2:158-9.
9. 9 Nouso K, Urabe Y, Higashi T, Nakutsakasa H, Hino N et al. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 1996;78:232-6.
10. 10 Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91:2900-4.
11. 11 Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyzek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-55.
12. 12 Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-6.
13. 13 Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M et al. Telomerase activity in human bladder cancer. Clin Cancer Res 1996;2:929-32.
14. 14 Kamata S, Kageyama Y, Yonese J, Oshima H. Significant telomere reduction in human superficial transitional carcinoma. Br J Urol 1996;78:704-8.
15. 15 Wisman GBA, Hollema H, de Jong S, ter Schegget J, Tjong A, -Hung SP et al. Telomerase activity as biomarker for (pre) neoplastic cervical disease in scrapings and frozen sections from patients with abnormal smears. J Clin Oncol 1998;16:2238-45.
16. 16 Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
17. 17 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem 1951;193:265.
18. 18 Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucl Acids Res 1995;23:3794-5.
19. 19 Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leucocytes and in hematologic malignancies. Blood 1995;85:2315-20.
20. 20 Takahashi C, Miyagawa I, Kumano S, Oshimura M. Detection of telomerase activity in prostate cancer by needle biopsy. Eur Urol 1997;32:494-8.
21. 21 Meeker AK, Sauvageot J, Coffey DS. Telomerase activity is a diagnostic marker for human prostate cancer and is applicable to needle biopsies. J Urol 1996;155:694A.
22. 22 Koeneman KS, Pan CX, Jin JK, Pyle JM, III, Flanigan RC et al. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN). J Urol 1998;160:1533-9.
23. 23 Zhang W, Kapusta LR, Slingerland JM, Klotz LH. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res 1998;58:619-21.
24. 24 Wullich B, Rohde V, Oehlenschläger B, Bonkhoff H, Ketter R et al. Focal intratumoral heterogeneity for telomerase activity in human prostate cancer. J Urol 1999;161:1997-2001.
25. 25 Sigala S, Faraoni I, Botticini D, Paez-Pereda M, Missale C et al. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines. Clin Cancer Res 1999;5:1211-8.
26. 26 Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 1992;83:159-64.
27. 27 Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T et al. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 1994;54:3557-60.